Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling
about
The Autoimmune EcologyMatrix metalloproteinases in kidney homeostasis and diseasesMatrix metalloproteinases, atherosclerosis, proteinuria and kidney disease: Linkage-based approachesType 1 diabetes: translating mechanistic observations into effective clinical outcomestPA is a potent mitogen for renal interstitial fibroblasts: role of beta1 integrin/focal adhesion kinase signalingIn vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetesDiabetes and immune thrombocytopenic purpura: a new association with good response to anti-CD20 therapy.Interleukin-35 induces regulatory B cells that suppress autoimmune disease.Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation.Immune tolerance induction by integrating innate and adaptive immune regulators.miRNAs: novel regulators of autoimmunity-mediated pancreatic β-cell destruction in type 1 diabetes.LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathwaysMulti-parametric flow cytometric and genetic investigation of the peripheral B cell compartment in human type 1 diabetes.Dysregulation of T lymphocyte proliferative responses in autoimmunity.tPA activates LDL receptor-related protein 1-mediated mitogenic signaling involving the p90RSK and GSK3beta pathwayTransforming growth factor-{beta}1 induces Smad3-dependent {beta}1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis.Sonic hedgehog is a novel tubule-derived growth factor for interstitial fibroblasts after kidney injury.Antigen-based vs. systemic immunomodulation in type 1 diabetes: the pros and cons.Altered B cell homeostasis and toll-like receptor 9-driven response in type 1 diabetes carriers of the C1858T PTPN22 allelic variant: implications in the disease pathogenesisStem cell treatment for type 1 diabetes.The dual role of scavenger receptor class A in development of diabetes in autoimmune NOD miceAn update on the use of NOD mice to study autoimmune (Type 1) diabetes.Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: immunologic effects and efficacy in NOD mice.B cells regulate neutrophilia during Mycobacterium tuberculosis infection and BCG vaccination by modulating the interleukin-17 response.LRP-1: functions, signaling and implications in kidney and other diseases.Hypoxia-inducible factor-1α contributes to the profibrotic action of angiotensin II in renal medullary interstitial cellsCurrent state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?Activatory and inhibitory Fcγ receptors augment rituximab-mediated internalization of CD20 independent of signaling via the cytoplasmic domainTissue-type plasminogen activator (tPA) promotes M1 macrophage survival through p90 ribosomal S6 kinase (RSK) and p38 mitogen-activated protein kinase (MAPK) pathwayExpansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response.Mannose receptor 2 attenuates renal fibrosisPivotal role of RanBP9 in integrin-dependent focal adhesion signaling and assembly.Tubular cell dedifferentiation and peritubular inflammation are coupled by the transcription regulator Id1 in renal fibrogenesis.Cellular and molecular mechanisms of renal fibrosis.Thinking bedside at the bench: the NOD mouse model of T1DM.New insights into epithelial-mesenchymal transition in kidney fibrosis.NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets.Tissue-type plasminogen activator suppresses activated stellate cells through low-density lipoprotein receptor-related protein 1Tissue plasminogen activator activates NF-κB through a pathway involving annexin A2/CD11b and integrin-linked kinase.Regulation of B lymphocyte responses to Toll-like receptor ligand binding during diabetes prevention in non-obese diabetic (NOD) mice
P2860
Q26747427-B20318B7-29BC-4FC5-9469-2C5BE3333259Q27004621-8BC6EEFB-1D36-4C68-96B6-8F48527233E9Q27025492-6B62CA51-A7D7-48F8-956A-284E1D2020B9Q28287737-F87A384D-23C0-4E38-9175-447FE68C1AF3Q28564568-C169FF56-3CA3-42A6-9770-5999338431BDQ28748969-0CDF6EBF-526F-4038-B1F1-899B5DF2FF0FQ33413423-003CC8D0-873F-46EA-B2CD-7AC3F0D21A76Q33721777-812BB74D-8E26-4A32-A038-67B708228A17Q33752988-B00E10A2-7F09-4ED8-AA8A-272E3FA9B58DQ33907609-3D180D2A-E9A7-4AE4-A613-5E3D46D4DE18Q33920162-0AC0E95C-6CCF-4785-B7AF-C213C4781125Q33996198-82590989-2D8B-4E3A-8722-7CA095489483Q34065354-24F3EE77-28DD-4C67-A13D-16E9281780C4Q34110530-37134C07-4005-4C4D-8E3D-78233FF1FFADQ34162322-9BE64C42-5A8F-4BC7-B61C-E7325329919EQ34162353-79E2C5DF-01E4-401B-A1E3-DBB82912D76FQ34260026-3EA8BA5C-E95F-496F-89E1-7826B50B0CBCQ34375578-6FBDE736-8981-4FB5-A324-BBCC4831E29CQ34380329-2734F716-A2F2-4862-BC6A-76F0473FE272Q34391021-E6A53A80-34CD-4153-B90A-E717648C7547Q34400478-448E450E-15B4-4A2A-BCF5-5D9D98713682Q34508281-135DB2CD-EEBC-4AD9-B0C8-FEF7ED774F19Q34583970-DF54B0E4-95E1-47DE-A87E-2E4473585A2FQ34819635-27E9D57A-EB4C-41F8-91DD-0A64D8A567E4Q34835060-67654846-48B6-495B-9A41-E0701CC1377CQ35022857-94BDF048-2868-45BD-9EB0-8CEA4ECAFEA7Q35116303-86BE868C-1010-4E55-B20A-60F6F489C82DQ35126604-0B07919A-7A76-4ABA-A7E2-600331224B52Q35199467-5CEAC349-D5BA-49B0-A93D-FFFFBD348BB7Q35654669-DA48FD09-3C65-4448-81B4-E2F0FF389E88Q35715763-F6CE44F7-F15B-473A-A828-3D9A3BDA24ABQ35863804-0DCF1E83-48C5-4CF1-B507-853B4AB88690Q35888486-B8502787-2981-4A59-8925-5AF83DD0C1A9Q35903772-07E543D3-06F3-432B-9480-0F53FD23A418Q35911875-2707FB6E-71BA-4970-BE45-825DA6685499Q36010095-785CEA40-2C70-43DD-A153-3B4F0CC4CE73Q36056835-DC40223E-101E-4840-AB6C-722EC0AD4CF8Q36101672-167BA3D0-82DF-4E16-9CFB-62DE7AE56F4BQ36109173-09B92BD2-5E3F-4190-80B4-5E7102CD01E6Q36137667-E44886EA-9EB0-4FD8-A17C-6DBB2AFBD3E8
P2860
Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tissue-type plasminogen activa ...... 1-mediated integrin signaling
@ast
Tissue-type plasminogen activa ...... 1-mediated integrin signaling
@en
type
label
Tissue-type plasminogen activa ...... 1-mediated integrin signaling
@ast
Tissue-type plasminogen activa ...... 1-mediated integrin signaling
@en
prefLabel
Tissue-type plasminogen activa ...... 1-mediated integrin signaling
@ast
Tissue-type plasminogen activa ...... 1-mediated integrin signaling
@en
P2093
P2860
P356
P1476
Tissue-type plasminogen activa ...... 1-mediated integrin signaling
@en
P2093
Chuanyue Wu
Wendy M Mars
Youhua Liu
P2860
P304
P356
10.1172/JCI32405
P407
P577
2007-12-01T00:00:00Z